Categories AlphaGraphs, Earnings, Health Care
Main highlights from Eli Lilly’s (LLY) Q3 2023 earnings results
Eli Lilly and Company (NYSE: LLY) reported third quarter 2023 earnings results today.
Worldwide revenue was $9.50 billion, up 37% compared to the same period a year ago.
Net loss was $57.4 million, or $0.06 per share, compared to net income of $1.45 billion, or $1.61 per share, last year. Adjusted EPS fell 95% to $0.10.
For the full year of 2023, revenue is expected to be $33.4-33.9 billion.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was